DEFA14A ·Filed Apr 24, 2026
Proxy solicitation materials
Actionable Insight • Neutral
This is a routine governance filing with no immediate trading implications. Monitor the company's next earnings release for material financial information.
Final — all horizons settled through T+60d
NKTR ▼ -20.08% at T+60d
NEUTRAL call ✗ call lost -20.08% · α vs SPY -24.86% · entry $86.74 → $69.32
T+1d
-3.38%
call -3.38% · α -2.89%
$83.81
settled 6mo ago
T+5d
+0.17%
call +0.17% · α -0.23%
$86.89
settled 6mo ago
T+20d
-24.42%
call -24.42% · α -29.37%
$65.56
settled 5mo ago
T+60d
-20.08%
call -20.08% · α -24.86%
$69.32
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Nektar Therapeutics filed a definitive proxy statement (DEFA14A) for its 2026 annual meeting, which includes routine matters such as the election of directors, executive compensation approval, and ratification of auditors. The filing is standard corporate governance and does not contain any material financial or strategic announcements.
Key Facts
- Filing is a standard proxy statement for an annual shareholder meeting
- Items include director election, executive compensation approval, and auditor ratification
- No material financial data, strategic announcements, or activist involvement mentioned
- Filing type is routine corporate governance
Financial Impact
No immediate financial impact expected
revenueepsdebtdilution
Risk Factors
- None identified in this filing
- Standard risks associated with pharmaceutical development pipeline
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (16 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001140361-26-016712 |
| Document: 0001140361-26-016712-index-headers.html | 0001140361-26-016712 |
| Document: 0001140361-26-016712-index.html | 0001140361-26-016712 |
| Document: 0001140361-26-016712.txt | 0001140361-26-016712 |
14 reports for NKTR
100% Hit rate best @ T+20▲ +28.57%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 13, 2026 9w ago | Press Release | $73.02 $68.50 | ▼ −6.19% | ▼ −4.20% | $35.78 (−51.00%) |
Aug 9, 2026 10w ago | Institutional Cluster | $74.86 $75.44 | ▲ +0.77% | ▲ +1.69% | $35.78 (−52.20%) |
Aug 7, 2026 10w ago | Court Ruling | $76.48 $74.19 | ▼ −2.99% | ▼ −2.60% | $35.78 (−53.22%) |
Jul 28, 2026 11w ago | Press Release | $70.68 $73.77 | ▲ +4.37% | ▼ −0.65% | $35.78 (−49.38%) |
Jun 11, 2026 18w ago | Institutional Cluster | $59.21 $72.92 | ▲ +23.15% | ▲ +21.26% | $35.78 (−39.57%) |
Jun 11, 2026 18w ago | Institutional Cluster | $59.21 $72.92 | ▲ +23.15% | ▲ +21.26% | $35.78 (−39.57%) |
May 21, 2026 21w ago | Insider Cluster | $66.61 $65.25 | ▲ +2.04% | ▲ +0.63% | $35.78 (+46.28%) |
May 8, 2026 23w ago | 8-K | $78.72 $56.23 | ▲ +28.57% | ▲ +28.27% | $35.78 (+54.55%) |
May 7, 2026 23w ago | 8-K | $81.89 $57.32 | ▼ −30.00% | ▼ −30.03% | $35.78 (−56.31%) |
Apr 24, 2026 25w ago | DEFA14A | $86.74 $65.56 | ▼ −24.42% | ▼ −29.37% | $35.78 (−58.75%) |
Showing 10 of 14
US Market Status
Market Closed — Opens in 29m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access